Skip to content
★ Sign in to follow
RS
Total declarations
15
Company
1
▲ Purchases (13 ops.)
€284k
▼ Sales (0 ops.)
—

Latest filing published 26 Jan 2021 for Opko Health, INC., €100k.

Filing timeline

BuySale
Robert Scott Fishel

Insider track record

Disclosed buys
13
Disclosed sells
0
Signal history

Closed purchases

Market purchases
13
Positive at T+90
77%
Median T+90
+57.3%

Based on 13 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 29 May 2019 · 2721 days ago · €86k
    +23.2%
    Entry US$1.85 · Close at T+365 US$2.28
  • Filed 10 Sept 2018 · 2982 days ago · €40k
    -53.3%
    Entry US$4.58 · Close at T+365 US$2.14
  • Filed 12 Jul 2018 · 3042 days ago · €13k
    -63.5%
    Entry US$5.86 · Close at T+365 US$2.14
  • Filed 30 May 2018 · 3085 days ago · €8,081
    -53.9%
    Entry US$3.88 · Close at T+365 US$1.79
  • Filed 15 May 2018 · 3100 days ago · €7,226
    -59.3%
    Entry US$4.99 · Close at T+365 US$2.03

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Robert Scott Fishel: trading record in brief

All filings by Robert Scott Fishel on record concern Opko Health, Inc. In total, 15 filings cover trades dated from 6 April 2018 to 25 January 2021.

No open-market sale appears; the market trades are 13 purchases worth €284k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 option exercises.

A typical purchase (the median) is worth €13k. 13 out of 13 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Looking at 13 purchases old enough to measure, the stock rose over the following 90 days in 77% of cases; the median change was +57.3%. Past outcomes like these are no guarantee of what comes next.

The newest entry dates from 26 January 2021: an option exercise of €100k, in Opko Health, Inc. The latest purchase dates back some time: it was published 2,721 days ago, on 29 May 2019. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Robert Scott Fishel

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ◇
    DirectorExecutivesOpko Health, Inc.
    121,600 USD13SEC
    40,000 shares@ US$3.0423.9% of flowCommon StockSEC:0001209191-21-005357:0
  • ◇
    DirectorExecutivesOpko Health, Inc.
    40,600 USD12SEC
    20,000 shares@ US$2.038.0% of flowCommon StockSEC:0001209191-21-005357:1
  • ▲
    DirectorExecutivesOpko Health, Inc.
    96,000 USD38SEC
    50,000 shares@ US$1.9230.2% of flowCommon StockSEC:0001209191-19-033120:0
    Canonical exit: 26 Aug 2019 (T+90)
  • ▲
    DirectorExecutivesOpko Health, Inc.
    46,300 USD30SEC
    10,000 shares@ US$4.6314.0% of flowCommon StockSEC:0001209191-18-050181:0
    Canonical exit: 6 Dec 2018 (T+90)
  • ▲
    DirectorExecutivesOpko Health, Inc.
    15,000 USD29SEC
    2,500 shares@ US$6.004.5% of flowCommon StockSEC:0001209191-18-042414:0
    Canonical exit: 9 Oct 2018 (T+90)
  • ▲
    DirectorExecutivesOpko Health, Inc.
    9,325 USD29SEC
    2,500 shares@ US$3.732.8% of flowCommon StockSEC:0001209191-18-034061:0
    Canonical exit: 27 Aug 2018 (T+90)
  • ▲
    DirectorExecutivesOpko Health, Inc.
    8,622 USD29SEC
    1,800 shares@ US$4.792.5% of flowCommon StockSEC:0001209191-18-030093:0
    Canonical exit: 12 Aug 2018 (T+90)
  • ▲
    DirectorExecutivesOpko Health, Inc.
    15,700 USD29SEC
    5,000 shares@ US$3.144.6% of flowCommon StockSEC:0001209191-18-028209:0
    Canonical exit: 2 Aug 2018 (T+90)
  • ▲
    DirectorExecutivesOpko Health, Inc.
    14,700 USD29SEC
    5,000 shares@ US$2.944.2% of flowCommon StockSEC:0001209191-18-026150:0
    Canonical exit: 24 Jul 2018 (T+90)
  • ▲
    DirectorExecutivesOpko Health, Inc.
    14,850 USD29SEC
    5,000 shares@ US$2.974.3% of flowCommon StockSEC:0001209191-18-026150:1
    Canonical exit: 24 Jul 2018 (T+90)
  • ▲
    DirectorExecutivesOpko Health, Inc.
    7,575 USD29SEC
    2,500 shares@ US$3.032.2% of flowCommon StockSEC:0001209191-18-026150:2
    Canonical exit: 24 Jul 2018 (T+90)
  • ▲
    DirectorExecutivesOpko Health, Inc.
    15,000 USD27SEC
    5,000 shares@ US$3.004.3% of flowCommon StockSEC:0001209191-18-025059:0
    Canonical exit: 15 Jul 2018 (T+90)
  • ▲
    DirectorExecutivesOpko Health, Inc.
    30,100 USD28SEC
    10,000 shares@ US$3.018.6% of flowCommon StockSEC:0001209191-18-025059:1
    Canonical exit: 15 Jul 2018 (T+90)
  • ▲
    DirectorExecutivesOpko Health, Inc.
    30,200 USD26SEC
    10,000 shares@ US$3.028.6% of flowCommon StockSEC:0001209191-18-024884:0
    Canonical exit: 12 Jul 2018 (T+90)
  • ▲
    DirectorExecutivesOpko Health, Inc.
    31,600 USD30SEC
    10,000 shares@ US$3.169.1% of flowCommon StockSEC:0001209191-18-024269:0
    Canonical exit: 5 Jul 2018 (T+90)

15 of 15 declarations